Nrg Therapeutics Ltd (11294505) is a private limited with share capital incorporated on 05/04/2018 (8 years old) and registered in stevenage, SG12FX. The company operates under SIC code 72110 and is classified as Micro.
Termination Director Company With Name Termination Date
Category:Officers
Date:04-02-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:04-02-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:12-12-2025
Accounts With Accounts Type Small
Category:Accounts
Date:13-10-2025
Memorandum Articles
Category:Incorporation
Date:28-08-2025
Resolution
Category:Resolution
Date:28-08-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:28-08-2025
Capital Allotment Shares
Category:Capital
Date:27-08-2025
Second Filing Change Details Of A Person With Significant Control
Category:Persons With Significant Control
Date:14-08-2025
Capital Allotment Shares
Category:Capital
Date:15-07-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:08-07-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:08-07-2025
Memorandum Articles
Category:Incorporation
Date:08-07-2025
Resolution
Category:Resolution
Date:08-07-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:02-07-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:02-07-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:02-07-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:15-06-2025
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:15-06-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:15-06-2025
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:15-06-2025
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:15-06-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:04-04-2025
Accounts With Accounts Type Small
Category:Accounts
Date:22-10-2024
Capital Allotment Shares
Category:Capital
Date:14-05-2024
Second Filing Capital Allotment Shares
Category:Capital
Date:13-05-2024
Second Filing Of Confirmation Statement With Made Up Date
Category:Confirmation Statement
Date:13-05-2024
Memorandum Articles
Category:Incorporation
Date:04-05-2024
Resolution
Category:Resolution
Date:04-05-2024
Capital Allotment Shares
Category:Capital
Date:01-05-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:04-04-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:19-10-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:19-10-2023
Accounts With Accounts Type Small
Category:Accounts
Date:07-09-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:12-04-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:05-04-2023
Change Person Director Company With Change Date
Category:Officers
Date:05-04-2023
Appoint Person Secretary Company With Name Date
Category:Officers
Date:21-12-2022
Move Registers To Sail Company With New Address
Category:Address
Date:25-10-2022
Change Sail Address Company With New Address
Category:Address
Date:25-10-2022
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:24-10-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:17-10-2022
Capital Allotment Shares
Category:Capital
Date:12-07-2022
Capital Alter Shares Subdivision
Category:Capital
Date:12-07-2022
Memorandum Articles
Category:Incorporation
Date:11-07-2022
Resolution
Category:Resolution
Date:11-07-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-07-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-07-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:06-07-2022
Capital Allotment Shares
Category:Capital
Date:06-07-2022
Capital Allotment Shares
Category:Capital
Date:06-07-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:06-07-2022
Termination Director Company With Name Termination Date
Category:Officers
Date:05-07-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:05-07-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:05-07-2022
Resolution
Category:Resolution
Date:22-06-2022
Resolution
Category:Resolution
Date:22-06-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:29-04-2022
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:26-01-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:26-04-2021
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:27-11-2020
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:06-04-2020
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:13-12-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:29-11-2019
Termination Director Company With Name Termination Date
Category:Officers
Date:12-08-2019
Termination Director Company With Name Termination Date
Category:Officers
Date:12-08-2019
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-08-2019
Appoint Person Director Company With Name Date
Category:Officers
Date:12-08-2019
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:17-04-2019
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:25-01-2019
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:25-01-2019
Incorporation Company
Category:Incorporation
Date:05-04-2018
Innovate Grants
1
This company received a grant of £1876420.0 for Development Of Mitochondrial Permeability Transition Pore Inhibitors For The Treatment Of Neurodegenerative Diseases. The project started on 01/05/2022 and ended on 31/07/2024.